Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers Read more about Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers Japan2017-567058Filed on 2017-12-25
COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME Read more about COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME Japan2023-575827Filed on 2023-12-08
ANTI-KRAS-G12D T CELL RECEPTORS Read more about ANTI-KRAS-G12D T CELL RECEPTORS US Application 18/423,020Filed on 2024-01-25
TEM8 ANTIBODIES AND THEIR USE Read more about TEM8 ANTIBODIES AND THEIR USE Hong Kong42020013010.2Filed on 2014-10-13
TEM8 Antibodies and Their Use Read more about TEM8 Antibodies and Their Use Australia2022200117Filed on 2019-10-24
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS Costa Rica2024-0019Filed on 2024-01-11
COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER Read more about COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER US Application 18/568,661Filed on 2023-12-08
PKM1/HLT2 NANOPARTICLE/HYDROGEL COMPOSITE FOR MIRNA DELIVERY Read more about PKM1/HLT2 NANOPARTICLE/HYDROGEL COMPOSITE FOR MIRNA DELIVERY Patent Cooperation TreatyPCT/US2024/011463Filed on 2024-01-12
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Read more about MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Japan2023-205633Filed on 2023-12-05
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Read more about MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Japan2022-177351Filed on 2022-11-04